Amebiasis is the third leading parasitic cause of death worldwide, and it is not known whether immunity is acquired from a previous infection. An investigation was done to determine whether protection from intestinal infection correlated with mucosal or systemic antibody responses to the Entamoeba histolytica GalNAc adherence lectin. E. histolytica colonization was present in 0% (0/64) of children with and 13.4% (33/246) of children without stool IgA anti-GalNAc lectin antibodies ( Amebiasis is estimated to result annually in 50 million cases of colitis and liver abscess and 100,000 deaths [1] . A major impediment to developing a vaccine is the lack of knowledge of the existence or nature of acquired immunity. Recent recognition of the distinction between invasive Entamoeba histolytica and noninvasive E. dispar has made many earlier studies of human immunity uninterpretable, since E. histolyticaspecific diagnostic tests were not used [1] [2] [3] . Case series of patients with amebic colitis in Natal, South Africa, and Dhaka, Bangladesh, show that there is a peak incidence of infection among children !14 years of age and a second increase in infection in adults 140 years old [4, 5] . This could be interpreted as evidence of acquired childhood immunity that wanes with advancing age. The development of invasive amebiasis in some E. histolytica-colonized individuals and documented second in- fections has led many to conclude that acquired immunity is nonexistent or, at best, incomplete [4, [6] [7] [8] .
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The amebic GalNAc lectin mediates adherence to and contactdependent cytolysis of human colonic mucosa and colonic epithelium [9] [10] [11] [12] . Serum IgG and secretory IgA antibodies to the lectin have been detected in patients with amebiasis [13] [14] [15] [16] [17] [18] . Our initial hypothesis was that serum IgG antilectin antibodies are a marker of systemic and mucosal immunity to E. histolytica. To test this hypothesis, we prospectively studied preschool children with and without lectin-specific serum IgG for new E. histolytica infections. Because of early results, we modified our study to focus on the association of mucosal antilectin IgA antibodies with protection from E. histolytica.
Materials and Methods
Study protocol. We studied preschool children (2-5 years old) from Mirpur, an urban slum in Dhaka. The inhabitants of Mirpur are of Bihari ethnic origin and settled there after the liberation of Bangladesh from Pakistan in 1971. The area is densely populated and has poor sanitary and hygienic conditions. Stool specimens were obtained every month for detection of E. histolytica infection by antigen capture and culture. Children and their parents were visited and interviewed every other day by health care workers. We also became aware of children with diarrhea when parents contacted project personnel at the field clinic. When diarrheal disease was detected, a stool sample was obtained and was examined for enteropathogens, and the child was examined. Samples were kept on ice, and they were transported to the laboratory for processing within 2-4 h.
Parents were instructed in the use of oral rehydration solution. Children were administered antibiotics, seen by a health care IgA in stool  Positive  0  64  0  64  Negative  33  213  16  230  Antilectin IgG in serum  Positive  26  120  15  131  Negative  7  157  1  163  Total children  33  277  16  294 NOTE. Plus (ϩ) and minus (Ϫ) signs indicate presence or absence of E. histolytica infection, respectively. worker, or hospitalized when appropriate. Four children with new E. histolytica infections developed dysentery and were treated for amebiasis with metronidazole. There is a low incidence of human immunodeficiency virus infection among high-risk groups in Dhaka (!3% in sex workers and injection drug users), so we did not test children for this disease [19] . Height and weight of the children were assessed by use of standard World Health Organization procedures [20] .
Diagnosis of E. histolytica infection. Infection was diagnosed by use of an E. histolytica antigen-specific test (E. histolytica II; TechLab), which was designed for use with stool samples. The test was used according to the manufacturer's instructions [21] . Stool samples were also cultured for Entamoeba species in Robinson's medium within 6 h of collection [22] . A new E. histolytica infection was defined as a positive E. histolytica stool antigen or culture result preceded by у2 monthly surveillance stool samples with negative results. Colonization with E. histolytica was defined as infection without dysentery or extraintestinal amebiasis.
ELISA for detection of serum and stool antilectin antibodies. The procedure used to detect anti-GalNAc lectin serum IgG and stool IgA antibodies by ELISA was modified from the procedure of Kelsall et al. [15] , who used microtiter plates coated with purified GalNAc lectin. A sample was considered positive for serum antilectin IgG if the optical density (OD) reading was у0.5, which is a cutoff point 13 SD above the mean of uninfected children in Dhaka and of negative serum samples from a country where E. histolytica is nonendemic. IgA was purified from stool samples, using anti-human IgA (a-chain-specific agarose, no. A22691; Sigma) according to the manufacturer's instructions. Stool samples containing 5 mg of total IgA were tested for GalNAc lectin-specific IgA. A sample was considered to be positive if the OD reading was у0.188, a cutoff point 12 SD above the mean of infected Dhaka children.
Statistical analysis. All data collected were computer-coded and analyzed by use of SPSS software (release 7.5; SPSS). Means of different variables were compared by use of Student's t test or, if the variables were not normally distributed, a nonparametric test. The x 2 test and Fisher's exact tests were used for categorical variables, to compare proportions between 2 groups. For all methods, a value of was considered to be significant. P ! .05
Results
As determined by antigen detection, asymptomatic E. histolytica infection was present in 4.3% (50/1164) of 2-5-year-old children in Mirpur. As we reported earlier, 100% of samples with positive culture results were also positive by antigen detection, and the test was not affected by the presence of antilectin IgA antibodies in stool (data not shown) [21] . We used polymerase chain reaction (PCR), which has a sensitivity of ∼75% compared with antigen detection, to test the 34 samples with culture-negative and antigen-positive results: 79% (27/34) of these specimens were positive by PCR, demonstrating that most of these samples represented true E. histolytica infection [21] .
Results of the cross-sectional survey of 310 children. Lectinspecific serum IgG was present in 14.6% (170/1164) of the children. Presence or absence of antilectin IgA in stool was determined in a subset of 310 of these children (approximately divided between those with and without lectin-specific serum IgG). Stool IgA antilectin antibodies were detected in 25.3% (37/146) Results of the prospective study. A 1-year prospective study was conducted on 289 of the 310 children, 93% (269/289) of whom were still in the study at 12 months. Of the 254 participating families, 29 had 2 children and 3 had 3 children participating. Among the 4 groups of children, there were no significant differences at the time of enrollment in age or nutritional status, although age was greater in seropositive children ( ) and P p .004 height was greater in seronegative children (  ; table 2 ). P p .01 The 289 children included subgroups of 145 children with and 144 without serum antilectin IgG at enrollment and 46 children with and 243 without stool IgA lectin-specific antibodies at enrollment ( figure 1; table 2 ). During the 12-month study, 39% (105/ 269) of the children had у1 new E. histolytica infection, with 3.1% (4/129) of the new infections associated with dysentery. ) at all time points, except at month 5. P ! .05 2 children was tested and was shown to inhibit amebic adherence to laminin (85% and 50% inhibition for the 2 IgA preparations;
, compared with a control). P ! .0001
Discussion
The major discovery of this study is the existence of acquired immunity to amebiasis. The presence of naturally acquired immunity to E. histolytica infection gives hope for the development of a colonization-blocking vaccine. Such a vaccine could eradicate amebiasis, as humans are the only known reservoir of infection.
Immunity is linked to a mucosal anti-adherence lectin IgA response. The association of mucosal antilectin IgA with protection was demonstrated in 3 ways. First, in a cross-sectional analysis, E. histolytica colonization was absent in all 64 children with stool antilectin IgA. Second, children with stool antilectin IgA acquired fewer new E. histolytica infections over a prospective period of observation. Last, the appearance of a stool IgA antilectin response coincided with the resolution of infection. Mucosal antilectin IgA is, therefore, an indicator of immune protection and may prove effective as a surrogate marker of vaccine efficacy.
It is tempting to speculate that stool IgA antilectin antibody is a mediator and not merely a marker of acquired immunity. The intestinal mucosa contains the highest number of immunoglobulin-producing cells of any organ, and its synthesis of IgA outstrips the body's production of all other immunoglobulins combined. Mucosal IgA has little inflammatory or complement activation activity, with its primary function thought to be the prevention of adherence of microorganisms to the gut epithelium [23] . IgA antibodies purified from stool samples from the children in this study neutralized the E. histolytica adherence lectin. This lectin mediates trophozoite adherence to human colonic mucin glycoproteins and colonic epithelium, the sites of natural infection, and is required for in vivo virulence [10] [11] [12] [23] [24] [25] [26] .
It seems likely that a cellular immune response acting at the mucosal level also contributes to the acquired immunity that we observed. A less than stringent requirement of cellular immunity for protection is suggested by the lack of any evidence that amebiasis is exacerbated in patients with AIDS [27] . However, activation of human macrophages and neutrophils with interferong and tumor necrosis factor (TNF)-a endows them with the ability to kill E. histolytica trophozoites, and in murine macrophages, TNF-a has been shown to activate macrophages for nitric oxide-dependent cytotoxicity against E. histolytica [28, 29] . It is important that future studies characterize the mucosal cellular immune responses in humans with acquired immunity.
There was no association of a systemic immune response, as monitored by serum IgG antilectin antibodies, to immunity from intestinal E. histolytica infection. This is potentially important information for the rational design of a vaccine, which, on the basis of the results of this study, should be targeted to the mucosal immune system. Others have noted a lack of correlation between mucosal and systemic responses in humans to the GalNAc lectin and the absence of an association of serum IgG antibodies with decreased colonization rates [15, 30] . In our study, we actually observed an increased frequency of new E. histolytica infections in children with serum IgG antibodies to the lectin. This increase could be due to the previously described presence of adherenceenhancing antilectin antibodies in serum leaking into the intestinal site of infection or to serum IgG antibodies identifying a population with increased risk for amebic infection within Mirpur (despite our attempts to match seropositive children with seronegative children) [17] . As an emphasis of the importance of mucosal immunity, the mucosal antilectin IgA response was associated with protection even in children with serum antilectin IgG: at 5 months, the cumulative incidence of infection was 5.9% (2/34) for IgA ϩ and IgG ϩ children versus 20.4% (48/235) for the rest of the children ( ). P p .04 Acquired immunity to most enteric infections is not under- stood. In the few cases in which it has been studied, evidence is split on the importance of systemic and mucosal responses. Vaccine-provided protection against polio colonization is associated with a duodenal IgA but not a serum IgG response [31] . Immunity to enterotoxigenic Escherichia coli is also linked to a local intestinal immune response and not to serum antibody responses to the bacterium [32] . Protection against rotavirus infection and disease correlates with both stool IgA antibody levels and serotype-specific serum-neutralizing antibody [33, 34] . A correlate of protection against reinfection with cholera is serum vibriocidal antibody [35] [36] [37] . Last, serum antibodies to Clostridium difficile toxin have been associated with protection from disease but not from colonization [38] . Subtle differences in the immunopathogenesis of these enteric infections may contribute to the relative importance of mucosal and systemic immunity in protection.
The acquired immunity that we observed was incomplete, with a decreased rate but not an absence of infections in children with IgA antilectin antibodies. Potential explanations include the short duration of detectable stool IgA production (as has also been seen with shigella and rotavirus infections), the ability of the parasite's cysteine proteinase to degrade IgA, and the presence of genetically distinct strains of E. histolytica in children in Mirpur (R.H., I.M.A., and W.A.P., unpublished data) [33, [39] [40] [41] . Further investigations on both host immune response and parasite genetic diversity will be required to design an effective E. histolytica vaccine, which now seems possible with the discovery of acquired immunity.
